Witnessing the stock’s movement on the chart, on November 15, 2021, Edwards Lifesciences Corporation (NYSE: EW) set off with pace as it heaved 0.59% to $116.69. During the day, the stock rose to $117.14 and sunk to $115.61 before settling in for the price of $116.00 at the close. Taking a more long-term approach, EW posted a 52-week range of $78.44-$123.27.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 12.00%. Meanwhile, its Annual Earning per share during the time was 11.70%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -21.00%. This publicly-traded company’s shares outstanding now amounts to $623.60 million, simultaneously with a float of $619.72 million. The organization now has a market capitalization sitting at $71.79 billion. At the time of writing, stock’s 50-day Moving Average stood at $116.05, while the 200-day Moving Average is $101.59.
If we measure the efficiency of the company that is accounted for 14900 employees. It has generated 294,383 per worker during the last fiscal year. Meanwhile, its income per employee was 55,262. The stock had 7.30 Receivables turnover and 0.64 Total Asset turnover. For the Profitability, stocks gross margin was +74.94, operating margin was +29.55 and Pretax Margin of +20.90.
Edwards Lifesciences Corporation (EW) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Medical Devices industry. Edwards Lifesciences Corporation’s current insider ownership accounts for 0.20%, in contrast to 86.10% institutional ownership. According to the most recent insider trade that took place on Nov 10, this organization’s CVP, TAVR sold 7,830 shares at the rate of 119.79, making the entire transaction reach 937,956 in total value, affecting insider ownership by 372,134. Preceding that transaction, on Nov 09, Company’s Chairman & CEO sold 32,550 for 119.90, making the whole transaction’s value amount to 3,902,872. This particular insider is now the holder of 188,002 in total.
Edwards Lifesciences Corporation (EW) Earnings and Revenue Records
As on 9/29/2021, Multinational firm has announced its last quarter scores, in which it reported $0.54 earnings per share (EPS) for the period topping the consensus outlook (set at $0.53) by $0.01. This company achieved a net margin of +18.77 while generating a return on equity of 18.88. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.59 per share during the current fiscal year.
Edwards Lifesciences Corporation’s EPS decrease for this current 12-month fiscal period is -21.00% and is forecasted to reach 2.58 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 15.53% through the next 5 years, which can be compared against the 11.70% growth it accomplished over the previous five years trading on the market.
Edwards Lifesciences Corporation (NYSE: EW) Trading Performance Indicators
Let’s observe the current performance indicators for Edwards Lifesciences Corporation (EW). It’s Quick Ratio in the last reported quarter now stands at 2.90. The Stock has managed to achieve an average true range (ATR) of 2.63. Alongside those numbers, its PE Ratio stands at $50.00, and its Beta score is 1.04. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 14.09. Similarly, its price to free cash flow for trailing twelve months is now 50.94.
In the same vein, EW’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 2.33, a figure that is expected to reach 0.55 in the next quarter, and analysts are predicting that it will be 2.58 at the market close of one year from today.
Technical Analysis of Edwards Lifesciences Corporation (EW)
Going through the that latest performance of [Edwards Lifesciences Corporation, EW]. Its last 5-days volume of 1.83 million was inferior to the volume of 2.43 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 24.10% While, its Average True Range was 2.69.
Raw Stochastic average of Edwards Lifesciences Corporation (EW) in the period of the previous 100 days is set at 69.45%, which indicates a major rise in contrast to 62.00% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 27.95% that was higher than 23.60% volatility it exhibited in the past 100-days period.